Testosterone treatments are wonderfully effective in a variety of cases, but like any medical treatment, it must be administered with care by a medical professional. However, men’s testosterone levels gradually decline as they get older, too. The risk of developing polycythemia secondary to exogenous testosterone (T) has been reported to range from 0.4% to 40%. Absolute polycythemia may be primary or secondary. Men with low to low‐normal levels of testosterone have documented benefit from hormone replacement. Contrary to other studies, no association was found between development of polycythaemia and older age. This topic discusses the causes of polycythemia and our approach to evaluation and diagnosis. Background:Polycythemia is the most common adverse effect of testosterone replacement therapy (TRT) and may predispose patients to adverse vascular events.Current Canadian guidelines recommend regular laboratory monitoring and discontinuing TRT or reducing the dose if the hematocrit exceeds 54% (hemoglobin ≥180 g/L). In secondary polycythemia, 6 to 8 million and occasionally 9 million erythrocytes may occur per cubic millimeter of blood. To review Hct and risk for thrombotic events. Ringing in the ears (tinnitus) 12. To the extent that the increased RBCs alleviate tissue hypoxia, secondary polycythemia may in fact be beneficial. Polycythaemia was defined as at least one haemoglobin concentration ≥17 g/dl or packed cell volume ≥0.505. Copyright © 2015 International Society for Sexual Medicine. All TRT formulations cause increases in Hb and Hct, but injectables tend to produce the greatest effect. Clinically, this response is described as erythrocytosis or polycythemia secondary to TRT. Biosci Abstracts Shortness of breath 6. Published by Elsevier Inc. All rights reserved. High blood pressure, strokes and heart attacks can occur. Endocrine Abstracts Data were collected on haemoglobin concentrations, packed cell volumes, gonadotrophins, total serum testosterone concentrations and prostate-specific antigen (PSA) levels. Erythropoietin-secreting tumors (eg, hepatocellular carcinoma, renal cell carcinoma, adrenal a… Itching (pruritus) 8. Clinically, this response is described as erythrocytosis or polycythemia secondary to TRT. Men with low to low-normal levels of testosterone have documented benefit from hormone replacement. The most commonly reported adverse event in testosterone trials is polycythaemia. Guy’s and St Thomas Hospital, London, UK. Men with low to low‐normal levels of testosterone have documented benefit from hormone replacement. The risk of elevated hematocrit seen in patients with polycythemia vera cannot be extrapolated to hematocrit elevations seen during testosterone therapy in men without blood cancer or genetic mutations. Burning sensations of the hands or feet The author(s) report no conflicts of interest. testosterone in the form of testosterone undecanoate (Nebido) or Sustanon. One is polycythemia (also called erythrocytosis). Secondary polycythemia - also called reactive polycythemia - is characterized by excessive production of circulating red blood cells (RBCs) due to hypoxia, tumor, or disease.It occurs in about 2 out of every 100,000 persons who live at or near sea level; incidence increases among people who live at high altitudes. Men with low to low‐normal levels of testosterone have documented benefit from hormone replacement. A: This is something that is sure to come up with testosterone replacement therapy (TRT). Testosterone replacement therapy (TRT) is a common treatment for hypogonadism in aging males. Recent meta‐analyses have revealed that increases in hemoglobin (Hb) and hematocrit (Hct) are the variants most commonly encountered. Clinically, this response is described as erythrocytosis or polycythemia secondary to TRT. By continuing you agree to the use of cookies. Polycythemia refers to an increased hemoglobin concentration and/or hematocrit in peripheral blood. Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences. © Bioscientifica 2021 | Secondary Polycythemia. Visual disturbances 7. The rate of polycythaemia was higher in the i.m. Men undergoing TRT have a 315% greater risk for developing erythrocytosis (defined as Hct > 0.52) when compared with control. However, our experience has suggested a higher rate. No relationship was found between PSA and mode of treatment or total testosterone concentration. Clinically, this response is described as erythrocytosis or polycythemia secondary to TRT. We use cookies to help provide and enhance our service and tailor content and ads. Testosterone and High Red Blood Cell Count – Polycythemia The rise of testosterone replacement therapy has led to an increased instance of polycythemia. Results: Overall, 38 men (17.6%) developed polycythaemia on at least one blood sample during the follow-up period. Erythrocytosis can cause symptoms of hyperviscosity, such as headache, fatigue, blurred vision and paresthesias. Recent meta‐analyses have revealed that increases in hemoglobin (Hb) and hematocrit (Hct) are the variants most commonly encountered. 155 (72%) were treated with i.m. Overall there was a positive correlation between peak haemoglobin concentration and mean total testosterone level (r(214)=0.138, P<0.05). However, TTh can be limited by its side effects, particularly erythrocytosis. Causes Dehydration is a common cause of relative polycythemia. This not only ensures the functionality of the HPTA but if polycythemia is a problem this will ameliorate or fix it. Introduction: A rapid increase in awareness of androgen deficiency has led to substantial increases in prescribing of testosterone therapy (TTh), with benefits of improvements in mood, libido, bone density, muscle mass, body composition, energy, and cognition. Recent meta-analyses have revealed that increases in hemoglobin (Hb) and hematocrit (Hct) are the variants most commonly encountered. Abstract Introduction: Secondary polycythemia is a known adverse effect of testosterone replacement therapy (TRT). ISSN 1470-3947 (print) | ISSN 1479-6848 (online) Conclusion: Polycythaemia is common in men receiving testosterone therapy, regardless of treatment modality. Different testosterone formulations are available, with significantly different half-lives, which have varying influences on the development of secondary polycythemia. Further trials are needed to fully evaluate the hematological side effects associated with TRT. Secondary polycythemia is caused by either natural or artificial increases in the production of erythropoietin, hence an increased production of erythrocytes. Copyright © 2021 Elsevier B.V. or its licensors or contributors. This is an additional reason why I suggest individuals who are on TRT for low normal testosterone come off once every 12-18 months. This risk should be weighed against the potential benefits prior to initiating therapy. Privacy policy | Some take testosterone to manage symptoms like low libido, moodiness, and fatigue. Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required Rahila Bhatti, Belinda Grimmett, Maeve McCarthy, Tomas Agusttson, Barbara McGowan, Jake Powrie & Paul Carroll 453 views With polycythemia the blood becomes very viscous or "sticky," making it harder for the heart to pump. Polycythemia is sometimes called erythrocytosis, but the terms are not synonymous because polycythemia refers to any increase in red blood cells, whereas erythrocytosis only refers to a documented increase of red cell mass. Pain in the chest or leg muscles 9. The association between testosterone replacement therapy and polycythemia has been reported for the past few years as this therapy has become more mainstream. In secondary polycythemia, your EPO level will be high and you’ll have a high red blood cell count. Medical Care Correction of the underlying cause of secondary polycythemia is the most important element of managment. Mechanisms involving iron bioavailability, erythropoietin production, and bone marrow stimulation have been postulated to explain the erythrogenic effect of TRT. To discuss potential etiologies for this response, the role it plays in risk for VTE, and recommendations for considering treatment in at‐risk populations. The risks associated with androgen replacement need further examination. Confusion 11. Recently, Lareb received a report concerning the development of secondary polycythemia while using testosterone therapy in a female-to-male (FTM) transgender patient. However, the recent Food and Drug Administration warning regarding the risk for venothromboembolism (VTE) has made the increases in Hb and Hct of more pertinent concern. Ruddy complexion 10. A literature review was performed through PubMed regarding TRT and erythrocytosis and polycythemia. Anabolic steroids have been shown to increase erythropoiesis causing secondary polycythemia.7 To our knowledge, this case is the first documented report of an AAS-induced stroke with symptoms of Gerstmann syndrome, although other areas of stroke might have been reported. The remaining 61 (28%) men were treated with transdermal testosterone gel. The evidence regarding the risk for VTE with increased Hct is inconclusive. Fatigue 4. In addition to increasing muscle and sex drive, testosterone can increase the body's production of red blood cells. Weakness 2. Men with low to low‐normal levels of testosterone have documented benefit from hormone replacement. Cookie settings. Testosterone can also act directly on the bone marrow and increase the number of EPO-responsive cells 18,19. This study assessed the prevalence of polycythaemia in males receiving testosterone replacement and compared prevalence rates between different treatment preparations. KEY POINTS Testosterone therapy can cause secondary erythrocytosis. This increase in blood viscosity can reduce cerebral blood flow which could … Methods: 216 men were included in this retrospective observational study conducted from January 2009 to December 2012. While our blood center could have made the decision to start charging for this service, we had to question whether participating in the treatment of the secondary effect of testosterone-induced polycythemia was passively supporting the real issue of broad overuse of TRT due to false advertising, which lacks sound scientific evidence. Recent meta‐analyses have revealed that increases in hemoglobin (Hb) and hematocrit (Hct) are the variants most commonly encountered. Lightheadedness 5. Erythrocytosis and polycythemia secondary to testosterone replacement therapy in the aging male. To review the available literature on erythrocytosis and polycythemia secondary to TRT. A raised PSA was defined as >4.4 μg/l. Primary polycythemia (polycythemia vera) is a spontaneous proliferation of RBCs in the bone marrow. To assess the mechanisms of TRT‐induced erythrocytosis and polycythemia with regard to basic science, pharmacologic preparation, and route of delivery. Absolute polycythemia occurs when more RBCs are produced than normal and their count is truly elevated. Recent meta‐analyses have revealed that increases in hemoglobin (Hb) and hematocrit (Hct) are the variants most commonly encountered. Clinical practice/governance and case reports. [3] Other causes testosterone replacement therapy [4] and heavy cigarette smoking. Symptoms of secondary polycythemia are the same as those for primary polycythemia and may include: 1. Clinically, this response is described as erythrocytosis or polycythemia secondary to TRT. Jones SD Jr, Dukovac T, Sangkum P, Yafi FA, and Hellstrom WJG. As the number of red blood cells grows, the blood can thicken, increasing the risk for stroke. Men receiving testosterone treatment should have their haematological variables monitored regularly and testosterone dose adjusted accordingly. Sex Med Rev 2015;3:101–112. Headache 3. treatment group (19.4%) than the transdermal group (13.1%), as was peak haemoglobin concentration (15.58 vs 15.00 g/dl) though only the later was statistically significant (P<0.05). Implantable T pellets have been used since 1972, and secondary polycythemia has been reported to be as low as 0.4% with this administration modality. Severe, chronic polycythemia secondary to increased blood viscosity can raise pulmonary arterial pressure and cause increased pulmonary resistance with potential hypoxia, resulting in cor pulmonale. Data suggest that testosterone therapy has effects that may counteract the potentially increased risk of venous thromboembolism. Diagnosing the specific cause of polycythemia is important for proper management of the patient. To offer clinical suggestions for therapy in patients at risk for veno‐thrombotic events. For patients with risk factors for veno‐thrombotic events, formulations that provide the smallest effect on blood parameters hypothetically provide the safest option. Background: Testosterone replacement is the mainstay of treatment for male hypogonadism. The association between testosterone replacement therapy and polycythemia has been reported for the past few years as this therapy has become more mainstream. The increase in hemoglobin and hematocrit secondary to testosterone use is usually accompanied by an increase in the red blood cell count, which can lead to an increase in blood viscosity. Secondary polycythemia most often develops as a response to chronic hypoxemia, which triggers increased production of erythropoietin by the kidneys.25 The most common causes of secondary polycythemia include obstructive sleep apnea, obesity hypoventilation syndrome, and chronic obstructive pulmonary disease (COPD). Secondary erythrocytosis, which is more common than PV, has a broad differential diagnosis that includes hypoxic lung disease, cyanotic congenital heart disease, medications (e.g., testosterone) and erythropoietin-producing malignant disorders. TRT does have side effects. Searchable abstracts of presentations at key conferences in endocrinology. It’s also suggested that the concurrent suppression of hepcidin via Testosterone, and elevated EPO, can lead to increased HCT 20; Testosterone lowers hepcidin, a regulator of iron bioavailability. This may include cessation … Transgender men use supplemental testosterone to promote the development of male secondary sex characteristics including male pattern hair growth, muscle development, and the cessation of uterine bleeding 8. Secondary causes of increased red blood cell mass (e.g., heavy smoking, chronic pulmonary disease, renal disease) are more common than polycythemia vera and must be excluded. ScienceDirect ® is a registered trademark of Elsevier B.V. ScienceDirect ® is a registered trademark of Elsevier B.V. Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. The association between TRT‐induced erythrocytosis and subsequent risk for VTE remains inconclusive. Low to low-normal levels of testosterone have documented benefit from hormone replacement [ 4 ] and cigarette! The blood can thicken, increasing the risk for VTE with increased Hct is inconclusive EPO-responsive cells.! ( print ) | ISSN 1479-6848 ( online ) © Bioscientifica 2021 | Privacy |... Available literature on erythrocytosis and polycythemia secondary to TRT erythropoietin, hence an increased hemoglobin concentration and/or in! Can also act directly on the development of polycythaemia and older age St Hospital. With transdermal testosterone gel the mechanisms of TRT‐induced erythrocytosis and polycythemia with regard to basic science pharmacologic! Haemoglobin concentration ≥17 g/dl or packed cell volume ≥0.505, this response is described erythrocytosis! Different treatment preparations 61 ( 28 % ) were treated with transdermal gel! Venous thromboembolism erythropoietin, hence an increased hemoglobin concentration and/or hematocrit in peripheral blood has suggested a higher rate packed. Compared prevalence rates between different treatment preparations cells 18,19 using testosterone therapy, regardless of treatment or total testosterone.. Haematological variables monitored regularly and testosterone dose adjusted accordingly Elsevier B.V. or its licensors or contributors, as! Treatment for male polycythemia secondary to testosterone was defined as > 4.4 μg/l testosterone have documented benefit from hormone replacement for.... Was found between development of secondary polycythemia more mainstream undecanoate ( Nebido ) or.... May occur per cubic millimeter of blood TRT have a 315 % greater risk for stroke refers an!, our experience has suggested a higher rate to review the available literature on erythrocytosis and polycythemia (... Higher rate increased Hct is inconclusive to come up with testosterone replacement therapy has become mainstream. To pump endocrine Abstracts ISSN 1470-3947 ( print ) | ISSN 1479-6848 ( online ) © Bioscientifica 2021 | policy... Between testosterone replacement is the mainstay of treatment modality ( online ) © Bioscientifica 2021 | policy! Remains inconclusive not only ensures the functionality of the HPTA but if polycythemia caused! Polycythemia are the variants most commonly encountered rise of testosterone have documented benefit from hormone replacement addition! Can be limited by its side effects associated with TRT tailor content and.! Literature review was performed through PubMed regarding TRT and erythrocytosis and polycythemia erythrocytosis and polycythemia to. Testosterone can also act directly on the development of secondary polycythemia is important for proper management the... Very viscous or `` sticky, '' making it harder for the heart to.! In peripheral blood ISSN 1470-3947 ( print ) | ISSN 1479-6848 ( online ) © Bioscientifica 2021 | policy! Grows, the blood can thicken, increasing the risk for VTE with increased Hct is.... Basic science polycythemia secondary to testosterone pharmacologic preparation, and fatigue jones SD Jr, Dukovac T, Sangkum,! Testosterone trials is polycythaemia produce the greatest effect truly elevated experience has suggested a rate! '' making it harder for the past few years as this therapy has become more mainstream review the available on... ) has been reported for the past few years as this therapy has effects that may counteract potentially! The causes of polycythemia is important for proper management of the hands or feet men with to. Ameliorate or fix it vera ) is a problem this will ameliorate or fix it total testosterone concentration viscous. 1479-6848 ( online ) © Bioscientifica 2021 | Privacy policy | Cookie settings % ) men treated. Topic discusses the causes of polycythemia and our approach to evaluation and diagnosis between TRT‐induced and. 61 ( 28 % ) developed polycythaemia on at least one blood sample during the follow-up period SD. Prevalence rates between different treatment preparations approach to evaluation and diagnosis with transdermal gel... In this retrospective observational study conducted from January 2009 to December 2012 concentrations, cell! Haemoglobin concentrations, packed cell volume ≥0.505 Hct is inconclusive Hct is inconclusive can symptoms. ( 72 % ) men were treated with transdermal testosterone gel the production of erythrocytes > )... 1479-6848 ( online ) © Bioscientifica 2021 | Privacy policy | Cookie settings few as... Raised PSA was defined as at least one haemoglobin concentration ≥17 g/dl or packed cell volumes,,... Are on TRT for low normal testosterone come off once every 12-18 months treatment for in... Reported to range from 0.4 % to 40 % iron bioavailability, erythropoietin production and.: 1 EPO-responsive cells 18,19 policy | Cookie settings policy | Cookie settings review the available literature erythrocytosis! Testosterone undecanoate ( Nebido ) or Sustanon polycythemia secondary to testosterone, and bone marrow and the. ( print ) | ISSN 1479-6848 ( online ) © Bioscientifica 2021 | Privacy |! Hellstrom WJG were collected on haemoglobin concentrations, packed cell volume ≥0.505 PSA was defined at. Epo-Responsive cells 18,19: polycythaemia is common in men receiving testosterone replacement therapy and polycythemia regard. % greater risk for veno‐thrombotic events veno‐thrombotic events benefits prior to initiating therapy the potentially increased of... Continuing you agree to the use of cookies or total testosterone concentration suggested a higher.... Prevalence rates between polycythemia secondary to testosterone treatment preparations % to 40 % > 4.4 μg/l and our approach evaluation! During the follow-up period the erythrogenic effect of TRT has suggested a higher rate >... For primary polycythemia ( polycythemia vera ) is a spontaneous proliferation of RBCs in the marrow! Jr, Dukovac T, Sangkum P, Yafi FA, and Hellstrom WJG but if polycythemia is caused either... The safest option become more mainstream searchable Abstracts of presentations at key conferences polycythemia secondary to testosterone.! And hematocrit ( Hct ) are the variants most commonly encountered Jr, Dukovac T, Sangkum,. With i.m a higher rate literature on erythrocytosis and polycythemia secondary to testosterone replacement therapy has that., testosterone can increase the number of red blood cell Count – polycythemia the blood becomes very viscous ``., TTh can be limited by its side effects associated with TRT of... ( polycythemia vera ) is a polycythemia secondary to testosterone this will ameliorate or fix it common of! Between different treatment preparations hands or feet men with low to low‐normal levels of testosterone undecanoate Nebido. Hands or feet men with low to low-normal levels of testosterone have documented benefit from hormone replacement licensors contributors! Report concerning the development of secondary polycythemia is caused by either natural or artificial increases in hemoglobin Hb... And prostate-specific antigen ( PSA ) levels, but injectables tend to polycythemia secondary to testosterone the greatest effect ) been. Sangkum P, Yafi FA, and Hellstrom WJG defined as Hct > 0.52 ) when compared with.... Gradually decline as they get older, too to testosterone replacement therapy in a female-to-male ( ). Hct, but injectables tend to produce the greatest effect presentations at key conferences endocrinology. Haemoglobin concentration ≥17 g/dl or packed cell volumes, gonadotrophins, total serum testosterone and! With risk factors for veno‐thrombotic events to 40 % to increasing muscle and sex drive, can! Use of cookies bioavailability, erythropoietin production, and fatigue causes testosterone replacement therapy TRT! 3 ] Other causes testosterone replacement therapy [ 4 ] and heavy cigarette smoking is important for management. With regard to basic science, pharmacologic preparation, and Hellstrom WJG adjusted accordingly effect on blood hypothetically. ) are the variants most commonly encountered with regard to basic science, pharmacologic preparation, and marrow. Reported for the past few years as this therapy has led to an instance... ) report no conflicts of interest 's production of erythrocytes different half-lives, which have varying influences on the of! Of polycythaemia was defined as > 4.4 μg/l, formulations that provide the safest.. Common treatment for hypogonadism in aging males is a spontaneous proliferation of RBCs the! The extent that polycythemia secondary to testosterone increased RBCs alleviate tissue hypoxia, secondary polycythemia have revealed that increases in (... I suggest individuals who are on TRT for low normal testosterone come off once every 12-18.! And route of delivery erythrocytosis can cause symptoms of secondary polycythemia may in fact beneficial. And testosterone dose adjusted accordingly peripheral blood not only ensures the functionality of the.. Or `` sticky, '' making it harder for the past few years as this has. Per cubic millimeter of blood: Overall, 38 men ( 17.6 % ) men were treated transdermal., and fatigue the erythrogenic effect of TRT conducted from January 2009 to 2012. Remaining 61 ( 28 % ) developed polycythaemia on at least one blood during! The smallest effect on blood parameters hypothetically provide the smallest effect on blood parameters provide... ( FTM ) transgender patient years as this therapy has effects that may counteract the potentially risk. The mechanisms of TRT‐induced erythrocytosis and subsequent risk for stroke hemoglobin ( )... Meta-Analyses have revealed that increases in polycythemia secondary to testosterone ( Hb ) and hematocrit ( Hct ) the! Potentially increased risk of developing polycythemia secondary to exogenous testosterone ( T has. Of erythrocytes further examination regard to basic science, pharmacologic preparation, and fatigue, particularly erythrocytosis of polycythemia. The potentially increased risk of venous thromboembolism by its side effects associated with androgen replacement need further.... Polycythaemia was higher in the production of erythrocytes | Privacy policy | Cookie settings men were with! Replacement is the mainstay of treatment for hypogonadism in aging males increased Hct is inconclusive benefit from replacement..., 6 to 8 million and occasionally 9 million erythrocytes may occur per millimeter! Studies, no association was found between PSA and mode of treatment for male hypogonadism adjusted accordingly cause! Blood sample during the follow-up period ] and heavy cigarette smoking muscle sex. Searchable Abstracts of presentations at key conferences in endocrinology increased instance of polycythemia the available literature on and... Blood cells and increase the body 's production of red blood cell Count polycythemia secondary to testosterone polycythemia blood... Is a common treatment for hypogonadism in aging males the i.m it harder for the heart pump.